EP4101855
Æxliseyðandi efnasambönd
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.4.2018EP published:
2.8.2023EP application number:
22187664.2
EP translation filed:
2.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
26.4.2038Expiry date:
26.4.2026Next due date:
30.4.2026
Title in English:
ANTITUMORAL COMPOUNDSLanguage of the patent:
English
Timeline
Today
27.4.2018EP application
2.8.2023EP Publication
2.10.2023Translation submitted
15.11.2023Registration published
26.4.2026Expires
Owner
Name:
Pharma Mar, S.A.Address:
Polígono Industrial La Mina Avda. de los Reyes, 1 Colmenar Viejo, 28770 Madrid, ES
Inventor
Name:
MARCHANTE, Maria del Carmen CuevasAddress:
E-28770 Madrid, ES
Name:
SOLLOSO, Andrés FranceschAddress:
E-28770 Madrid, ES
Name:
BARRASA, Valentin MartinezAddress:
E-28770 Madrid, ES
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
17382228Date:
27.4.2017Country:
EP
Number:
17382497Date:
26.7.2017Country:
EP
Classification
Categories:
C07D 515/22, A61P 35/00, A61K 31/4995
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 2.4.2024
Expires: 26.4.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 16.4.2025
Expires: 26.4.2026
Payer: Árnason Faktor ehf.